retatrutide alternative for Weight Loss: TRIUMPH-1 Results, Cost, Insurance Retatrutide Peptide vs Tesamorelin: Mechanisms,

It is not formulated, packaged, or labelled for human use, and it is not authorized by Health Canada for any human or veterinary indication

Discontinuing treatment should be discussed with a medical practitioner, as lifestyle changes may be needed to maintain results

Bone, sweet boneosteoporotic fractures in diabetes mellitus

2025, doi: 10.1016/j.neurot.2025.e00712

A head-to-head comparison trial with 800 patients will give direct results in late 2026

Originally approved by the FDA for the treatment of adult obesity in 2014, the drug received authorisation in 2020 for obesity in adolescents aged 12-17 years old (Mller, Blher, Tschp, DiMarchi)